Alfacalcidol-D6 atracurium besylate Drug Formulation: This drug may

Drug Formulation: This drug may be formulated in DMSO

COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4C5=CC=CC=C5NC=4[C@@H]3C[C@@H]21

UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation

CAS Number: 1185763-69-2

CAS Number: 1579991-61-9

Alfacalcidol-D6 atracurium besylate Drug Formulation: This drug mayAlfacalcidol D6, a deuterated Alfacalcidol (1 hydroxycholecalciferol; Alpha D3; 1. alpha. Hydroxyvitamin D3), is a non selective VDR activator medication. IC50 value: Target: VDR activatorAlfacalcidol (1 hydroxycholecalciferol; Alpha D3; 1. alpha. Hydroxyvitamin D3) improves mechanical bone strength and bone mass; suppresses osteoclastic bone resorption in vivo. Product information CAS Number: 1641940 94 4 Molecular Weight: 406. 67 Formula: C27H44O2